クレイホームズ

Corporate Corporate Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center  Digital Showroom  Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Products Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investors Investors Management Policy Message from the President --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data ∟Financial Highlight ∟Historical DATA  Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information ∟Stock Information ∟Dividend ∟Shareholders Meeting ∟Articles of Incorporation ∟Ratings and Bonds Sustainability Sustainability Sustainability Activities Sustainability Approach and Promotion Structure Material Issues and　Sustainability(MOS) Indices​ ESG Initiatives Environment Social Governance Sustainability Data Sustainability (MOS) Results Non-Financial Data Sheets GRI Standards Integrated report "KAITEKI Report" News News Releases Information IR News TSE Filings Contact Us 日本語 English 中文 --> --> --> --> HOME Innovation Main R&D Organization : Mitsubishi Chemical Corporation Performance Polymers Technology Center Performance Polymers Technology Center Mitsubishi Chemical Corporation 　①TEFABLOC™ QE with enhanced scratch and abrasion resistance TEFABLOC™ QE series has been developed with unique formulation and compounding technology to achieve better scratch and abrasion resistance with smooth surface finishing without treatments such as painting and coating. Applications: automotive interior skin such as instrument panel, console, grip, knob. ②Polymer/Elastomer with excellent blood compatibilities We have developed Zelas™ AMP with hemocompatibility for plasma, platelets. Zelas™AMP can impart hemocompatibility to thermoplastic resins such as vinyl chloride resin (PVC) for blood tubing and bags, TPU for catheter and PP/PMMA for laboratory supplies and diagnosis. Zelas™AMP is a revolutionary technology that allows thermoplastic resins to be made blood-compatible through normal processing processes (injection, extrusion), eliminating the need for coating processes. Cooperation of Professor Masaru Tanaka, Soft Materials Chemistry, Institute for Materials Chemistry and Engineering, Kyushu University https://www.m-chemical.co.jp/en/products/departments/mcc/mcpp/expo/1214423_7758.html ③Material with low dielectric loss We developed Tefabloc™ CP with low dielectric loss for use in high-speed communication applications such as 5G and 6G .We are able to customize products according to the requests. We have also developed metal-adhesive and solvent-soluble grades using resin-modification technology, and design products in line with customer requirements. ④Zelas™ CP with low adsorption performance of low molecular weight pharmaceuticals/biopharmaceuticals Using our compound formulation techniques, we have developed Zelas™ CP, which adsorbs less proteins such as antibodies (IgG) and plasma (Fibrinogen). Zelas™ CP also show low adsorption with low molecular drugs. 主なR&D組織--> Main R&D Organization Innovation Science & Innovation Center Specialty Materials Information & Electronics Technology Center Films Technology Center Advanced Materials Technology Center Life Solution Technology Center Performance Polymers Technology Center Polymers & Compounds / MMA Polymers Research & Development Center Coating & Additives R&D Center MMA R&D Center Award　History Paper submission Corporate Information Corporate Information Corporate Information Basic Information Message from the President Corporate Profile / Access ∟Mitsubishi Chemical Group Corporation ∟Mitsubishi Chemical Corporation ∟Mitsubishi Tanabe Pharma Corporation ∟Nippon Sanso Holdings Corporation Leadership Organization Chart Global Network Number of Subsidiaries History Corporate Brochure Evaluation by Outside Parties Approach to Corporate Activities Group Concept Charter of Corporate Behavior Value Creation Model Health and Productivity Management Management Strategy Management Policy Business Strategy ∟Specialty Materials ∟Industrial Gases ∟Health Care ∟MMA ∟Petrochemicals and Carbon Products Governance Corporate Governance ∟Corporate Governance Guidelines Risk Management Compliance Media KAITEKI Solution Center Digital Showroom Social Media ∟LinkedIn account  ∟X account  ∟YouTube channel  Business・Products Business・Products Innovation Innovation Innovation CTO Message --> Innovation Strategy Intellectual Property Strategy Mitsubishi Chemical Corporation R&D Main R&D Organization Award History Paper Submission Investor Relations Investor Relations Investor Relations Management Policy Message from the President --> Message from the CFO --> Outside Directors’ Discussion Meeting --> Management Policy Disclosure Policy IR News IR News TSE Filings Basic Information Chart IR Calendar Financial Data Evaluation by Outside Parties (ESG) Other IR Information ∟FAQ on IR ∟Contact on IR ∟IR Sitemap IR library Financial Results Operating Summaries Analysts Meeting Materials Integrated Reports Securities Reports Report in Line with the Recommendations of the TCFD To Our Individual Investors The Mitsubishi Chemical Group in Numbers Stock and Bond Information Sustainability Sustainability Sustainability Sustainability Activities Sustainability approach and promotion structure Material Issues and Sustainability(MOS) Indices ESG Initiatives Environment Society Governance Sustainability Data Sustainability (MOS) results Non-Financial Data Sheets GRI Standards KAITEKI Solution Center News Releases Information Digital Showroom Contact Us FAQ The Mitsubishi Chemical Group Official Accounts Sitemap Terms of Use Privacy Policy Social Media Terms of Use Copyright © Mitsubishi Chemical Group Corporation.